the only FDA-approved treatment option was tobramycin solution for inhalation (TSI). The US Cystic Fibrosis Foundation currently recommends TSI every other month for chronic therapy of cystic ...

Cipla to introduce Afrezza, an inhaled insulin for diabetes, offering convenience but not advised for lung-related concerns.